The contents of glycogen and fat and the activities of glucose-6-phosphatase (G6Pase), glucose-6-phosphate dehydrogenase (G6PD), glycolysis and lipogenesis were investigated in the livers from three patients with Type I of glycogen storage disease. The contents of glycogen and fat were markedly increased. The activity of G6Pase was definitely low and that of G6PD was normal or slightly increased. The activity of glycolysis was elevated and that of lipogenesis from glucose seemed to be accelerated.
In our preceding studies on congenital steatosis of the liver1'2), it was found that there were a decrease in glucose-6-phosphatase (G6Pase) activity, an in crease in glucose-6-phosphate dehydrogenase (GOD) activity and an enhancement in activity of glycolysis and of lipogenesis from glucose in the liver from an infant with congential steatosis of the liver. In conclusion, we presumed that con genital steatosis of the liver had a defect of G6Pase in common with Type I of glycogen storage disease (von Gierke's disease) and that an enhanced lipogenesis from carbohydrate, probably due to increased activity of pentose phosphate pathway, played an important role in the development of fatty liver in con genital steatosis.
It has been known3-7) that considerable amounts of fat often accumulate in the liver of von Gierke's disease. In this respect, the present paper reports the results of our investigations upon activity of glycolysis and of lipogenesis in the livers from three children with von Gierke's disease. METHODS 
AND MATERIALS
Three patients with typical von Gierke's disease were subjected to the present investigation. These three children showed short stature, immense abdomi nal distension due to massively enlarged liver, a tendency to adiposity and occasional episodes of epistaxis. Laboratory examinations revealed a fasting hypoglycemia, a poor response of blood sugar to adrenaline, and striking eleva tions of blood lactic and pyruvic acids, and of serum total lipids, triglycerides, phospholipids, and cholesterol (cf. Table I ). The liver biopsy showed a marked accumulation of fat as well as glycogen (cf. Fig. 1 ). demonstrated an almost normal activity of G6PD in the liver from a patient with G6Pase deficiency glycogen storage disease. Our present results were in favor of Howell's observation, and indicated a normal or somewhat high level of G6PD activity and a remarkably low level of G6Pase activity in the livers from three patients with von Gierke's disease (cf. Table II) . Such a discrepancy respecting G6PD activity by different investigators may be ascribed to the fact that the enzyme G6PD is very unstable in homogenate of human liver15). It has been known16) that elevations of lactate and pyruvate in blood are frequently seen in patients with von Gierke's disease. Our own patients also showed elevations of lactate and pyruvate in blood (cf. Table I ). There are reports'5,11) that further elevation of lactate in blood following the administration of glucagon or epinephrine, which does not occur in normal individuals, does occur in patients with this particular disease. In normal individuals, the administra tion of glucagon or epinephrine results in a sharp rise in blood glucose but in no rise in blood lactate, while it results in an obvious elevation of blood lactate and in a slight rise in blood sugar in patients with von Gierke's disease. This phenomenon is interpreted as follows18). In normal individuals, glycogenolytic agents such as glucagon or epinephrine stimulate breakdown of glycogen and subsequently increase in free glucose in blood. On the other hand, in von Gierke's disease glucose-6-phosphate produced as an intermediate of glycogen breakdown by the agent may be degradated to pyruvate and lactate via Embden-Meyerhof or pentose phosphate pathway, since the liver of the disease is unable to dephosphor ylate glucose-6-phosphate and to discharge glucose into blood.
The results obtained in the present studies that the liver from the patient with von Gierke's disease showed an enhanced activity of glycolysis will give us a direct evidence for the assumption mentioned above (cf. Table III) .
The conversion of glucose to fat by the livers of this particular disease was found to be accelerated as was evidenced by the present studies (cf . Table IV) . This finding is essentially in agreement with that in the patient with congenital steatosis reported by us1,2). In our previous papersh2), it was reported that the liver from a patient with congenital steatosis had a definitely decreased activity of G6Pase, an increased activity of G6PD and an enhanced activity of glycolysis and lipogenesis. Therefore, the difference in metabolic abnormality between congenital steato sis of the liver and von Gierke's disease may be not qualitative but quantitative . It is conceivable that congenital steatosis of the liver may be an extreme case of type I of glycogen storage disease as regards fat accumulation in the liver .
As was discussed in previous papers as to the development of fatty liver in congenital steatosisl.2), an enhanced lipogenesis from carbohydrate might play an important role in fat accumulation in the liver of von Gierke's disease .
Although it is difficult to understand why lipogenesis is accelerated in this 
